Corticosteroids: Triamcinolone, Dexamethasone and Fluocinolone.
Steroids have been extensively used to treat macular edema due to diabetic retinopathy, venous occlusive disease, ocular inflammation and, to a lesser extent, also in some cases of choroidal neovascularization. The various intraocular steroids that have been employed include dexamethasone, triamcinolone and fluocinolone. During the past few years, new drug delivery methods for corticosteroids have been developed and are now part of our therapeutic armamentarium. This chapter provides a brief description of the pharmacology, efficacy and adverse effects associated with the use of steroids in various retinal diseases.
Javier
J
Cáceres-del-Carpio
Rodrigo Donato
RD
Costa
Asghar
A
Haider
Raja
R
Narayanan
Baruch D
BD
Kuppermann
D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016503:Drug Delivery Systems; D005446:Fluocinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008269:Macular Edema / Q000188:drug therapy*; D014221:Triamcinolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D005938:Glucocorticoids; D005446:Fluocinolone Acetonide; D014221:Triamcinolone; D003907:Dexamethasone; C035394:fluocinolone